Health

Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation

-- Issues Statement in Response to DOMA’s Nomination of Director Candidates --  -- No Shareholder Action Required at This Time…

4 months ago

Commit Biologics appoints serial biotech founder as new CEO to take complement-powered immune engagers into the clinic

Dr. Thomas L. F. Montgomery Andresen joins from T-Cypher BioFollows breakthrough non-human primate data demonstrating deep B-cell depletion without cytokine…

4 months ago

Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement

The agreement enables a full tech transfer of the chikungunya vaccine for future supply to low- and middle-income countries.Expanded collaboration…

4 months ago

Propr Introduces Propr Paste, Completing Its Clinically Inspired System for Gentle, Long-Term Oral Health

New York, NY, March 11, 2026 (GLOBE NEWSWIRE) -- Propr®, the fluoride free oral care brand founded by leading periodontist…

4 months ago

Natural Remedies Advances Sleep Health Research with Holixer During National Sleep Awareness Month

BANGALORE, India, March 10, 2026 (GLOBE NEWSWIRE) -- During National Sleep Awareness Month in March, Natural Remedies is highlighting human clinical…

4 months ago

NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimers Disease at AD/PD 2026

March 10, 2026 08:05 ET  | Source: NKGen Biotech, Inc. SANTA ANA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- NKGen…

4 months ago

API Innovation Center Highlights Fragility in U.S. Drug Supply Chain in New White Paper

ST. LOUIS, March 10, 2026 (GLOBE NEWSWIRE) -- The API Innovation Center (APIIC), a nonprofit dedicated to strengthening national health security…

4 months ago

Surgery Partners, Inc. to Present at Upcoming Investor Conference

March 09, 2026 12:04 ET  | Source: Surgery Partners, Inc. BRENTWOOD, Tenn., March 09, 2026 (GLOBE NEWSWIRE) -- Surgery Partners,…

4 months ago

Zealand Pharma to participate in upcoming investor conferences in March 2026

March 09, 2026 12:01 ET  | Source: Zealand Pharma Press release – No. 5 / 2026 Zealand Pharma to participate…

4 months ago

CORRECTING & REPLACING — MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism

Following End-of-Phase 2 meeting, MBX remains on track to initiate Phase 3 in Q3 2026 March 09, 2026 10:21 ET…

4 months ago